(vi) In IDH1/2 mutation negative AML, the emergence of IDH1 or IDH2 mutations at relapse was observed in 10% in our study, which suggests the subclonal, late origin of these mutations. This evidence concerns the gene IDH2 and acute myeloid leukemia.